Intervet

EQUINE RHINOPNEUMONITIS - INFLUENZA VACCINE

KILLED VIRUS

A combination of inactivated, purified, concentrated, adjuvanted, tissue culture origin Equine Herpesviruses EHV-1 and EHV-4 and Equine Influenza Virus subtype A2 including KY93, KY02, and NM2/93 strains. Intervet serological data suggest Influenza cross protection against certain U.S. and European strains, including Kentucky 91, 93, 99, 02, Ohio 03, Newmarket/1/93, Newmarket/2/93, Suffolk 89, and South Africa 03.

INDICATIONS: For vaccination of healthy horses, 6 months of age or older, as an aid in the control of respiratory disease caused by Equine Influenza Virus and Equine Herpesvirus and as an aid in the reduction of Influenza virus shedding. Duration of immunity (DOI) has been shown to be at least 6 months for Influenza. Foals nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.

DOSE: For primary immunization, aseptically inject 1 mL intramuscularly and repeat the dose in 3 to 4 weeks. A booster dose can be administered at more frequent intervals based upon individual horse or farm disease risk assessment or any time epidemic conditions exist or are reported. Consult your veterinarian.

CAUTIONS: Store at 35° to 45°F (2° to 7°C). Shake well before using. Use entire contents when first opened (10 doses). Do not vaccinate within 21 days before slaughter. Local reactions may occur if this product is given subcutaneously. Inject deep into the muscle only. Anaphylactoid reactions may occur.

CAUTION: Needle is sharp and may cause injury to self or animals if not handled properly or disposed of properly.

ANTIDOTE: Epinephrine.

Thimerosal added as a preservative.

*Adjuvant-Intervet's Proprietary Technology.

FOR USE IN ANIMALS ONLY

Intervet Inc., Millsboro, DE 19966

1-800-441-8272

www.intervetusa.com

U.S. Veterinary License No. 286

NAC No.: 11061272